
Voglitip-MF 500mg/0.3mg Tablet
Marketer
Zodley Pharmaceuticals Pvt Ltd
Salt Composition
Metformin (500mg) + Voglibose (0.3mg)
Overview Voglitip-MF 500mg/0.3mg Tablet
Diabeva-Duo 500mg/0.3mg tablets are classified as antidiabetic medications. This dual-action formulation treats type 2 diabetes in adults by regulating blood glucose. Diabeva-Duo should be ingested with meals, consistently at the same time daily for optimal effectiveness. Dosage is determined by your physician and may be adjusted based on blood sugar monitoring. Continued use is crucial, even with well-managed blood sugar, as discontinuation without medical consultation risks elevated glucose levels, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. Remember, this medication complements a comprehensive diabetes management plan encompassing diet, exercise, and weight management as directed by your doctor. Lifestyle choices are integral to diabetes control. Possible side effects, such as nausea, altered taste, appetite changes, gas, abdominal discomfort, diarrhea, and skin rashes, are generally transient and self-limiting. Persistent or concerning side effects warrant medical attention; your doctor can offer management strategies. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Individuals with a history of heart disease should inform their physician before initiating treatment. Pregnant or lactating women should seek medical advice prior to use. Regular blood glucose monitoring is essential, and supplementary blood tests to assess blood cell counts and liver function may be recommended.
Primary Ingredients of Voglitip-MF 500mg/0.3mg Tablet
The provided text is "undefined," which cannot be rephrased while maintaining meaning and intent. There is no original meaning or intent to preserve.
Uses of Voglitip-MF 500mg/0.3mg Tablet
Managing type 2 diabetes
Major Benefits of Voglitip-MF 500mg/0.3mg Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Voglitip-MF 500mg/0.3mg tablet whole; do not bite, pulverize, or fracture it. Administer this medication with a meal.
Common Side effects of Voglitip-MF 500mg/0.3mg Tablet:
- Flatulence
- Diarrhea
- Abdominal pain
- Vomiting
- Decreased appetite
How to use Voglitip-MF 500mg/0.3mg Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Voglitip-MF 500mg/0.3mg tablet whole; do not chew, crush, or fracture it. Administer this medicine with a meal.
How Voglitip-MF 500mg/0.3mg Tablet works:
Each Voglitip-MF 500mg/0.3mg tablet contains a dual antidiabetic formulation.
SAFETY ADVICE
AlcoholUNSAFE
Combining alcohol and Voglitip-MF 500mg/0.3mg tablets is not advisable due to safety concerns.
PregnancyCONSULT YOUR DOCTOR
The use of Voglitip-MF 500mg/0.3mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the potential advantages against any possible risks prior to prescribing. Physician consultation is advised.
Breast feedingCONSULT YOUR DOCTOR
Using Voglitip-MF 500mg/0.3mg tablets while breastfeeding is likely inadvisable. Available human data indicates potential transfer of the medication into breast milk, posing a risk to the infant.
DrivingSAFE
Driving ability is typically unaffected by Voglitip-MF 500mg/0.3mg Tablets. Nevertheless, patients should be aware of the potential for low blood sugar (hypoglycemia) if this medication is taken concurrently with other diabetes medications like sulfonylureas, insulin, or repaglinide.
KidneyCAUTION
Patients with kidney impairment should use Voglitip-MF 500mg/0.3mg Tablets cautiously, potentially requiring dosage modification. Physician consultation is recommended. The use of Voglitip-MF 500mg/0.3mg Tablets is contraindicated in patients exhibiting severe kidney disease. Regular monitoring of renal function is advised during treatment.
LiverCONSULT YOUR DOCTOR
Insufficient data exists regarding the use of Voglitip-MF 500mg/0.3mg tablets in individuals with hepatic impairment. Physician consultation is advised.
What if you forget to take Voglitip-MF 500mg/0.3mg Tablet :
Should you forget a Voglitip-MF 500mg/0.3mg Tablet dose, administer it immediately. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Voglitip-MF 500mg/0.3mg Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Medication |
